Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,042 | 67 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $323.96 | 19 | $0 (2024) |
| Alkermes, Inc. | $228.23 | 14 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $226.81 | 16 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $105.93 | 9 | $0 (2020) |
| Allergan Inc. | $72.94 | 5 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $31.16 | 1 | $0 (2017) |
| Vanda Pharmaceuticals Inc. | $27.27 | 2 | $0 (2019) |
| AbbVie Inc. | $25.79 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.12 | 4 | Janssen Pharmaceuticals, Inc ($84.12) |
| 2022 | $83.64 | 4 | Janssen Pharmaceuticals, Inc ($45.86) |
| 2021 | $182.31 | 12 | Janssen Pharmaceuticals, Inc ($86.95) |
| 2020 | $163.59 | 11 | Janssen Pharmaceuticals, Inc ($95.75) |
| 2019 | $217.68 | 15 | Alkermes, Inc. ($118.02) |
| 2018 | $111.07 | 8 | Otsuka America Pharmaceutical, Inc. ($40.25) |
| 2017 | $199.68 | 13 | Otsuka America Pharmaceutical, Inc. ($74.73) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Neuroscience | ||||||
| 07/24/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Neuroscience | ||||||
| 06/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: Neuroscience | ||||||
| 06/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Neuroscience | ||||||
| 09/07/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: CNS | ||||||
| 08/17/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Neuroscience | ||||||
| 06/01/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: CNS | ||||||
| 05/11/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Neuroscience | ||||||
| 12/15/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Neuroscience | ||||||
| 12/08/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: PSYCHIATRY | ||||||
| 11/10/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: PSYCHIATRY | ||||||
| 10/27/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Neuroscience | ||||||
| 10/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Neuroscience | ||||||
| 08/25/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: CNS | ||||||
| 08/18/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: PSYCHIATRY | ||||||
| 06/02/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Neuroscience | ||||||
| 03/31/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), SPRAVATO | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Neuroscience | ||||||
| 03/03/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: PSYCHIATRY | ||||||
| 01/20/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Neuroscience | ||||||
| 12/02/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Neuroscience | ||||||
| 12/01/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: CNS | ||||||
| 10/26/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Neuroscience | ||||||
| 09/23/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Neuroscience | ||||||
| 08/12/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 35 | 39 | $28,501 | $5,121 |
| 2022 | 3 | 96 | 363 | $43,349 | $13,530 |
| 2021 | 3 | 141 | 378 | $46,804 | $14,753 |
| 2020 | 3 | 175 | 595 | $68,048 | $22,334 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 35 | 39 | $28,501 | $5,121 | 18.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 45 | 293 | $26,663 | $8,364 | 31.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 34 | $10,710 | $3,269 | 30.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 25 | 36 | $5,976 | $1,896 | 31.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 77 | 300 | $27,300 | $8,643 | 31.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 36 | 44 | $13,860 | $4,237 | 30.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 28 | 34 | $5,644 | $1,874 | 33.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 96 | 503 | $45,773 | $15,073 | 32.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 42 | 47 | $14,805 | $4,730 | 32.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 37 | 45 | $7,470 | $2,531 | 33.9% |
About Dr. Merry De Leon, MD
Dr. Merry De Leon, MD is a Psychiatry healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710078258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Merry De Leon, MD has received a total of $1,042 in payments from pharmaceutical and medical device companies, with $84.12 received in 2024. These payments were reported across 67 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,042).
As a Medicare-enrolled provider, De Leon has provided services to 447 Medicare beneficiaries, totaling 1,375 services with total Medicare billing of $55,738. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Minneapolis, MN
- Active Since 09/28/2006
- Last Updated 04/02/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1710078258
Products in Payments
- INVEGA SUSTENNA (Drug) $296.88
- ARISTADA (Drug) $211.31
- ABILIFY MAINTENA (Drug) $208.13
- LATUDA (Drug) $105.93
- VRAYLAR (Drug) $98.73
- INGREZZA (Drug) $31.16
- Fanapt (Drug) $27.27
- SPRAVATO (Drug) $27.08
- REXULTI (Drug) $18.68
- Aristada 441 mg (Drug) $16.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Minneapolis
Dr. Sophia Vinogradov, Md, MD
Psychiatry — Payments: $33,782
Dr. John Simon, M.d, M.D
Psychiatry — Payments: $33,198
Ziad Nahas, Md, MD
Psychiatry — Payments: $21,831
Dr. Alik Widge, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $13,727
Dr. Brian Johns, Md, Mfa, MD, MFA
Psychiatry — Payments: $6,599
Dr. Gihyun Yoon, M.d, M.D
Psychiatry — Payments: $3,607